Raymond W. Cohen
Raymond W. Cohen is a Life Science Executive. He had been CEO of Vessix Vascular, Inc. (formerly Minnow Medical), a venture-capital backed developer of a novel device treatment for patients with hypertension and peripheral vascular disease. Cohen also currently serves as a venture partner to Fjord Ventures, LLC., a life-science incubator located in Laguna Hills, CA and, in addition, serves as a member of the board of directors of several public and private medical technology firms including: BioLife Solutions, Inc. (BLFS) a manufacturer of cryopreservation products used for human cell and tissue preservation; Syncroness, Inc., a privately-held engineering and product development firm; CardioPolymers, Inc., a venture-capital backed developer of novel biotherapeutic therapies for congestive heart failure patients; and Cardiogenesis, Inc. (CPCG), a manufacturer of transmyocardial revascularization lasers.
From 2006-2010 Cohen served as CEO of CardioPolymers, Inc., and previously as Chairman and Chief Executive Officer of Nasdaq-listed Cardiac Science, Inc. In 2004, Cardiac Science was ranked as the fourth fastest growing technology company in North America on Deloitte & Touche's Fast 500 listing. In 2008, Cohen was named by AeA as the Private Company Life Science CEO of the Year. He was named Entrepreneur of the Year in 2002 by the Orange County Business Journal and was a finalist for Ernst & Young's Entrepreneur of the Year in the medical company category in 2004. Cohen is a member of a number of local Southern California business and educational organizations.
Cohen is an Accredited Public Company Director and holds a BS in business management from the State University of New York at Binghamton.